Clinical trial
Combination Chemotherapy Followed by Radiation Therapy in Patients With Small…
NCT00002822 · Medical Research Council, Other · Completed
Key facts
| NCT number | NCT00002822 |
|---|---|
| Title | Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer |
| Official title | RANDOMISED CLINICAL TRIAL OF IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE WITH MID-CYCLE VINCRISTINE (VICE) VERSUS STANDARD PRACTICE CHEMOTHERAPY IN PATIENTS WITH LIMITED STAGE SMALL CELL LUNG CANCER (SCLC) AND GOOD PERFORMANCE STATUS |
| Lead sponsor | Medical Research Council, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | carboplatin, cisplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, ifosfamide, mesna, vincristine sulfate, radiation therapy |
| Enrollment | 400 |
| Start date | Mar 1, 1996 |
| Completion | Nov 1, 2005 |
| First posted | Apr 16, 2003 |
| Last update posted | Dec 19, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: